Covington Investment Advisors Inc. increased its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 15.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 20,602 shares of the semiconductor company’s stock after acquiring an additional 2,688 shares during the quarter. Synopsys comprises 1.2% of Covington Investment Advisors Inc.’s portfolio, making the stock its 28th biggest holding. Covington Investment Advisors Inc.’s holdings in Synopsys were worth $9,190,000 as of its most recent SEC filing.
Other large investors have also added to or reduced their stakes in the company. CTC Alternative Strategies Ltd. bought a new position in Synopsys during the second quarter worth $500,000. Headlands Technologies LLC boosted its holdings in shares of Synopsys by 144.0% during the 2nd quarter. Headlands Technologies LLC now owns 6,516 shares of the semiconductor company’s stock worth $2,907,000 after buying an additional 3,846 shares during the period. Moore Capital Management LP boosted its holdings in shares of Synopsys by 41.3% during the 2nd quarter. Moore Capital Management LP now owns 19,790 shares of the semiconductor company’s stock worth $8,828,000 after buying an additional 5,780 shares during the period. Two Sigma Securities LLC acquired a new position in Synopsys in the 2nd quarter valued at about $452,000. Finally, Benjamin Edwards Inc. raised its holdings in Synopsys by 10.0% in the 2nd quarter. Benjamin Edwards Inc. now owns 2,473 shares of the semiconductor company’s stock valued at $1,103,000 after acquiring an additional 225 shares during the period. Institutional investors own 85.47% of the company’s stock.
Synopsys Price Performance
Shares of Synopsys stock opened at $439.59 on Tuesday. The company has a quick ratio of 1.24, a current ratio of 1.34 and a debt-to-equity ratio of 0.29. The stock has a market capitalization of $84.24 billion, a price-to-earnings ratio of 77.67, a price-to-earnings-growth ratio of 2.42 and a beta of 1.23. Synopsys, Inc. has a twelve month low of $366.00 and a twelve month high of $615.79. The company has a 50-day simple moving average of $416.14 and a two-hundred day simple moving average of $440.15.
Insider Activity at Synopsys
In related news, CEO Sassine Ghazi sold 14,603 shares of the stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the sale, the chief executive officer owned 75,020 shares of the company’s stock, valued at $34,431,179.20. This represents a 16.29% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the firm’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the transaction, the chief financial officer owned 14,358 shares in the company, valued at approximately $6,461,387.16. This trade represents a 19.12% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 42,997 shares of company stock worth $19,368,311. Company insiders own 0.56% of the company’s stock.
Analysts Set New Price Targets
Several equities research analysts have issued reports on the stock. UBS Group set a $570.00 price objective on shares of Synopsys in a research report on Thursday. Zacks Research lowered Synopsys from a “strong-buy” rating to a “hold” rating in a research note on Friday, August 21st. Benchmark reiterated a “buy” rating and set a $570.00 target price on shares of Synopsys in a research note on Thursday, August 27th. Bank of America lifted their price target on Synopsys from $515.00 to $600.00 and gave the stock a “buy” rating in a report on Thursday, May 28th. Finally, Weiss Ratings upgraded Synopsys from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday. Twelve investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Synopsys currently has a consensus rating of “Moderate Buy” and a consensus target price of $561.28.
Read Our Latest Research Report on Synopsys
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Recommended Stories
- Five stocks we like better than Synopsys
- Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
- Insiders Are Betting Big on These 3 Healthcare Stocks
- 3 Stocks for Investors Who Still Believe Cash Is King
- Dollar General and Dollar Tree Are Recovering, But Not for the Same Reason
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
